Home News Deals, joint ventures & alliances

OEL enters into joint venture to manufacture and market ultrasound machine that decreases cost of care for patients with tumours

Felicia Tan
Felicia Tan6/9/2020 02:59 PM GMT+08  • 2 min read
OEL enters into joint venture to manufacture and market ultrasound machine that decreases cost of care for patients with tumours
OEL (Holdings), the provider of various engineering, trading, and contracting solutions, has entered into a joint venture agreement (JVA) with Shanghai Suntec to manufacture and market High-Intensity Focused Ultrasound (HIFU) machines on Tuesday.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

SINGAPORE (June 9): OEL (Holdings), the provider of various engineering, trading, and contracting solutions, has entered into a joint venture agreement (JVA) with Shanghai Suntec to manufacture and market High-Intensity Focused Ultrasound (HIFU) machines on Tuesday.

Both companies will jointly manufacture and distribute the machines, as well as provide installation, medical, and equipment after-sales services under its joint venture company in Singapore (JV Company).

The JV Company will manufacture the HIFU machine, while the medical team at Shanghai Longjian Hospital Management (Shanghai Longjian) will oversee the machines’ medical services such as medical training, remote surgery guidance, and purchase material.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.